Clinical Trials Logo

Terminal Care clinical trials

View clinical trials related to Terminal Care.

Filter by:
  • None
  • Page 1

NCT ID: NCT05351281 Recruiting - Quality of Life Clinical Trials

Appropriate Medication Use in Dutch Terminal Care

AMUSE
Start date: April 29, 2022
Phase: N/A
Study type: Interventional

The AMUSE trial is a multicentre stepped-wedge cluster randomized controlled trial where medication optimization of patients with a life expectancy of less than three months is investigated by using CDSS-OPTIMED (a personalized medication advice to attending physicians of patients in the last phase of life) The investigators will include 250 patients, in 7 different study sites across the Netherlands. The primary outcome is an assessment of the quality of life of patients, two weeks after baseline assessment.

NCT ID: NCT05108792 Completed - Terminal Care Clinical Trials

Continuous Deep Sedation Until Death

SPCMD-REA
Start date: February 26, 2021
Phase:
Study type: Observational

This research is a descriptive observational study conducted in multicenter (intensive care and continuing care units) in France. All data collected is part of the patient record. The main objective is to describe the end-of-life sedative practices following a decision to limit or stop therapy in intensive care unit and continuing care unit.

NCT ID: NCT04271085 Completed - Terminal Care Clinical Trials

Living Well, Dying Well. A Research Programme to Support Living Until the End

iLIVE
Start date: September 1, 2020
Phase:
Study type: Observational

The iLIVE project involves a cohort study in which patients with an estimated life expectancy of six months or less are followed until they die. In total, the investigators will include 2200 patients in 11 countries, i.e. 200 per country. The primary outcome for the cohort study is a descriptive assessment of the concerns, expectations and preferences around dying and end-of-life care of patients and their relatives, in different settings and cultures..

NCT ID: NCT04171830 Enrolling by invitation - Screening Clinical Trials

Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life

HOMR
Start date: June 17, 2019
Phase: N/A
Study type: Interventional

One of the most important obstacles to improving end-of-life care is the inability of clinicians to reliably identify those who are approaching the end-of-life. Every aspect of a palliative approach to care - screening for unmet needs, treating symptoms, discussing goals of care, and developing a palliative management plan - depends on the reliable and accurate identification of patients with palliative needs. The investigators developed an accurate and reliable mortality prediction tool that automatically identifies patients in hospital at elevated risk of death in the coming year. In previous studies it has been shown that these patients also frequently have unmet palliative care needs at the time they are identified by the tool. This tool has been demonstrated feasible, acceptable to patients and providers, and effective for changing physician behaviour in an inpatient clinical context. In this project, this tool is implemented as part of an integrated knowledge translation project to facilitate reliable and timely identification of unmet palliative needs across multiple hospitals with different clinical settings and contexts. The investigators have partnered with 12 hospitals to improve the quality of palliative and end-of-life care provided to patients and families. With each partner site the investigators will develop a comprehensive implementation plan, including stakeholder engagement, education, and feedback. Process measures will be collected at each site to determine whether the tool was effective for promoting the identification and documentation of unmet palliative needs. Patients who were identified by the tool will also be followed over time to collect outcome and impact measures to see if their end-of-life care was affected by the intervention compared to control groups.

NCT ID: NCT01933789 Completed - Heart Failure Clinical Trials

Improving Communication About Serious Illness

ICSI
Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to improve care delivered to patients with serious illness by enhancing communication among patients, families, and clinicians in the outpatient setting. We are testing a new way to help patients share their preferences for talking about end-of-life care with their clinicians and families. To do this we created a simple, short feedback form. The form is designed to help clinicians understand what patients would like to talk about. The goal of this research study is to show that using a feedback form is possible and can be helpful for patients and their families.

NCT ID: NCT00105599 Completed - Neoplasm Clinical Trials

Effectiveness of the FairCare System for Patients With Advanced Illness

Start date: n/a
Phase: Phase 2
Study type: Interventional

This study of the FairCare Program (FC) is designed to address end of life (EOL) care delivery issues by reducing barriers to effective EOL care among health care providers, family members, surrogates, and Chronic Heart Failure (CHF) patients using a comprehensive, multi-pronged approach delivered by a care coordinator and supported by an interdisciplinary team.